3 0
Read Time:41 Second

The Growing Anxiety Of The New COVID Variant Omicron, Hyderabad Based Vaccine Producer Bharat Biotech Covaxin Got Conformation  From  Drug Controller General Of India (DGCI) For Emergency Usage For Childrens Age Among 12-18 Years. This Make The Covaxin Vaccine The Second Vaccine  For The Safe Use For Childrens In India. Zydus Cadila’s Three Dose DNA Vaccine Is  Preffered To Be Used On Adults And Children Over The Age Of 12. Meantime, PM Narendra Modi Decleared On Saturday That The Vaccination Opposed To COVID-19 For The Children Among 15-18 Years Age Will Begin From January 3, At The Same Time “Precaution Dose” For Healthmaintainance Workers And Frontline Workers Would Be Managed From January 10. India’s COVID Omicron Catalog Crossed 450 Mark With Maharashtra Reporting Highest Counting Of Cases In The Country.

Happy
Happy
100 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *